Cardiotropic Gene Therapy for Heart Failure: Translational Lessons From AB‐1002
Open Access
- 29 January 2026
- journal article
- Published by Wiley in MedComm – Future Medicine
- Vol. 5 (1)
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Cardiotropic AAV gene therapy for heart failure: a phase 1 trialNature Medicine, 2025
- State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial DiseasesEuropean Journal of Heart Failure, 2024
- AAV-mediated gene therapy: Advancing cardiovascular disease treatmentFrontiers in Cardiovascular Medicine, 2022
- Cardiac I-1c Overexpression With Reengineered AAV Improves Cardiac Function in Swine Ischemic Heart FailureMolecular Therapy, 2014
- Enhancement of Cardiac Function and Suppression of Heart Failure Progression By Inhibition of Protein Phosphatase 1Circulation Research, 2005